Atlas Trials

Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response

Clinical trial NCT02852486 · COMPLETED

Trial details

NCT number
NCT02852486
Sponsor
University of Campinas, Brazil
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia, Chronic Myeloid
Start date
2016-06-22
Primary completion
2024-02-07
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.